Cited by CrossRef (16)
- Xiangjin Wang, Lijiao Wu, Maobin Yu, Hao Wang, Langyu He, Yilang Hu, Zhaosen Li, Yuqin Zheng, Bo Peng. Exploring the molecular mechanism of Epimedium for the treatment of ankylosing spondylitis based on network pharmacology, molecular docking, and molecular dynamics simulations. Mol Divers 2025;29:591

- Anja Meyer. Illuminating the impact of γδ T cells in man and mice in spondylarthritides. Eur J Immunol 2024

- Howook Jeon, Hong Ki Min. Advancements in Imaging Techniques for Early Diagnosis and Management of Axial Spondyloarthritis. Curr Rheumatol Rep 2025;27

- Yu-Seon Jung, Soo-Kyung Cho, Se Rim Choi, Sun-Young Jung, Yoon-Kyoung Sung. Evolving trends in the prevalence and treatment of ankylosing spondylitis in Korea from 2010 to 2023: a population-based study. Sci Rep 2025;15

- Hui-Chun Yu, Sz-Tsan Wang, Ming-Chi Lu. Dysregulated Non-Coding RNA Expression in T Cells from Patients with Ankylosing Spondylitis Contributes to Its Immunopathogenesis. Biomedicines 2024;12:1873

- Yuchang Fei, Huan Yu, Yulun Wu, Shanshan Gong. The causal relationship between immune cells and ankylosing spondylitis: a bidirectional Mendelian randomization study. Arthritis Res Ther 2024;26

- Sumyah Hussein Hassan, Ibtesam Ghadban Auda, Ekhlass N. Ali, Mohammed Hadi Alosami, Ranya H. Hussein. Role of endoplasmic reticulum aminopeptidase-1 gene polymorphism (rs13167972) in occurrence susceptibility of ankylosing spondylitis in a sample of Iraqi male patients. Mol Biol Rep 2024;51

- A.L. Seufert, H. Struthers, L. Caplan, R.J. Napier. CARD9 in the pathogenesis of axial spondyloarthritis. Best Practice & Research Clinical Rheumatology 2024;38:101964

- Yekui Luo, Yonghuan Chen, Xiangning Yan, Lan Zhang, Yuan Shang, Jae Chul Seo, Mohammad Ali. Effectiveness of exercise intervention in relieving symptoms of ankylosing spondylitis: A network meta-analysis. PLoS ONE 2024;19:e0302965

- Lei Zhangni, Xiao Mofan, Chen Yuling, Li Yingchao. Clinical features and fecal microbiota characteristics of patients with both ulcerative colitis and axial spondyloarthritis. BMC Gastroenterol 2024;24

- Oznur Sadioglu Cagdas, Neslihan Gokcen, Ayten Yazici, Ayse Cefle. Monitoring disease activity and treatment response in ankylosing spondylitis: a retrospective study of hematologic inflammatory markers. Rheumatol Int 2024;45

- Wenjie Xia, Lvjiong Zhou, Weiqin Gao, Yating Zhang, Fangyuan Si, Fengmin Bai, Zhanming Zhang, Weifeng Wang, Guangjie Chen, Chenxin Gao, Xiaotong Li, Tao Yue. Patient self-reported experience and satisfaction with golimumab and etanercept treatments for rheumatic diseases: A cohort study. 2024;103:e36982

- Nilasree Hazra, Sudeshna Sengupta, Dipannita Burman, Jyoti Sekhar Banerjee, Malavika Bhattacharya. Unraveling ankylosing spondylitis: Exploring the genetic and immunological factors and latest treatment innovations. Advances in Biomarker Sciences and Technology 2025;7:21

- Mengyang Ma, Zhihua Yang, Ke Li, Lu Yang, Bozhen Chen, Meiqi Chen, Haifang Du, Yingyan Zhou, Xiaohong He, Yiting He. Molecular insights into the therapeutic mechanisms of Bushen-Qiangdu-Zhilv decoction for ankylosing spondylitis. Journal of Ethnopharmacology 2025;340:119269

- Oh Chan Kwon, Hye Sun Lee, Juyeon Yang, Min-Chan Park. Risk of Cancers According to the Use of Biological Agents in Patients With Radiographic Axial Spondyloarthritis. J Clin Rheumatol 2025

- Yu Jeong Lee, Zijun Li, Hyun Hee Jang, Moon-Ju Kim, Kandasamy Saravanakumar, Seung Cheol Shim, Namki Cho, Eun Jeong Won, Tae-Jong Kim. Usenamine A: a potential therapeutic agent for rheumatoid arthritis and ankylosing spondylitis through its anti-inflammatory activity. Front. Pharmacol. 2024;15
